Yoo Ah-in, Who Faced 'Drug Use' Allegations, Makes Comeback with 'Exhumation' Director… 'Vampire' Begins Filming
Three Years of Self-Reflection, First Official Activity in Four Years
Yoo Ah-in Confirmed to Make Comeback During Probation Period
Featuring Lee Seong-min, Lee Jun-hyuk, Doi, Yoon Kyung-ho, and Choi Hyun-wook
[E-Daily Starin Choi Hee-jae Reporter] Actor Yoo Ah-in has officially announced his return three years after taking a hiatus due to drug use. This marks his first public appearance in the media in four years. Yoo Ah-in (Photo courtesy of NEW) On the 18th, the production team of the film “Vampire” announced the start of filming, stating, “We have finalized the cast lineup and will begin full-scale filming in August.” Along with this announcement, photos of Yoo Ah-in at a script reading were released, drawing significant attention. Yoo Ah-in, who has been on trial since 2023 on charges including drug use and was sentenced to probation, is set to reappear in public after three years of self-reflection. This marks his first public appearance in a creative project—rather than in a courtroom—in four years, since the 2022 film *The Match*. Previously, the drama *The Fool at the End of the World* (2024) and the films *The Match* (2025) and *High Five* (2025) had their release dates postponed due to the controversy surrounding Yoo Ah-in, and he was unable to attend their official events. “Vampire” is a mystery-occult film depicting the events that unfold when an unidentified hitman, commissioned by a clergyman, pursues a group of mysterious heretics. Director Jang Jae-hyun, who has showcased unparalleled storytelling and solid directing skills in every film—including *Exhumation*, *Sabah*, and *The Priests*—plans to once again expand his unique cinematic universe through *Vampire*. Rumors of Yoo Ah-in’s casting in “Vampire” have been circulating since last year, but his agency has maintained a cautious stance, stating, “Nothing has been decided yet.” However, after eyewitness accounts spread last July that Director Jang and Yoo Ah-in attended the VIP screening of “Hope” together, his casting in “Vampire” was widely regarded as a foregone conclusion. In *Vampire*, Yoo Ah-in plays a bounty hunter tracking down a cult. Though he is a bold character who remains unflappable in any situation, the film will depict his gradual transformation as he confronts mysterious beings. From the top left, clockwise: Lee Sung-min, Lee Jun-hyuk, Choi Hyun-wook, Yoon Kyung-ho, Kim Do-i (Photo courtesy of NEW) Lee Sung-min plays a clergyman who breaks taboos for the sake of his beliefs. Drawing on his solid acting chops, he delivers a profound portrayal of a character torn between responsibility and guilt, anchoring the drama. Lee Jun-hyuk showcases a bold transformation as a heretic who yearns for eternal life. He is expected to dominate the screen by bringing this mysterious character to life with a sharp, intense aura. Rookie actress Do-i has been cast as the girl shrouded in mystery. Having been selected after surviving a fierce audition process, she is expected to radiate fresh energy and leave a lasting impression. Yoon Kyung-ho takes on the role of a smuggling broker who ends up traveling with the heretic. Yoon Kyung-ho is set to add vibrancy to the film with his signature, realistic acting style. Finally, Choi Hyun-wook joins the cast as a U.S. Army second lieutenant with a mysterious agenda. He is expected to heighten the film’s tense atmosphere with his nuanced, multi-dimensional performance that captures even the subtlest emotions. The synergy between these actors, each with such intense individuality, is expected to create the explosive ensemble unique to *Vampire*. “Vampire” is scheduled for theatrical release in 2028.
“At Kim & Chang, we collaborate organically with industry-specific practice groups during mergers and acquisitions (M&A), so we can always rely on the assistance of fellow experts who are well-versed …
Psomagen, Inc.(950200)announced on the 14th, through its 2026 interim financial statements, that it recorded an operating profit of $93,000 (140 million won) in the first half of the year, successfull…
DuChemBio Co.,LTD.(176750), a company specializing in radiopharmaceuticals, announced on the 18th that it recorded sales of 20.9 billion won and operating profit of 3.2 billion won in the first half o…